🦊/Investors

BlueStone Venture Partners β€” Full Portfolio

12 tracked investments Β· listed companies and verified rows first

Strateosstrateos.comin𝕏Apr 2019βœ“ verified

Strateos develops remote access laboratory software and automation platforms that enable scientists to design, execute, and analyze experiments through cloud-based robotics and control systems.

AI & Machine LearningBiotechDeep TechRoboticsSaaSMenlo Park, US

Chris Krueger(Executive Officer)inMark Fischer-Colbrie(Executive Officer, Director)inDavid Lynch, PhD(Chief Executive Officer)Marc Siladi(Chief Operating Officer)in

BoardJoshua Wolfe(Director)Armen Vidian(Director)in

Co-investorsDCVC (Data Collective)Lux CapitalThird Rock VenturesHarmonix FundSilicon BadiaAlly Bridge Group+3 more

Akadeum Life Sciencesakadeum.comin𝕏

Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US

Kalyan Handique(Executive Officer, Director)John Younger(Executive Officer, Director)inJames Militello(Executive Officer)

BoardJeffrey S. Williams(Director)Paul D'Amato(Director)inDan Kidle(Director)in

Co-investorsArboretum VenturesBeringeaBerkeley CatalystCANTILEVER INVESTORSeLab VenturesHemisphere Ventures LLC+7 more

CND Life Sciencescndlifesciences.comin

CND Life Sciences develops skin-based neurodiagnostic tests, including a test to detect abnormal alpha-synuclein in skin biopsies to help physicians diagnose Parkinson's disease and related synucleinopathies.

BiotechDigital HealthMedical DevicesScottsdale, US

Todd Levine(Executive Officer, Director)inRichard J. Morello(Executive Officer, Director)Peter Harris(Executive Officer, Director)inChristopher Gibbons(Director)

BoardJack Seaver(Director)Enrique Carrazana(Director)

Co-investorsTop Corner Capital

Elucidelucid.comin𝕏

Elucid develops artificial intelligence technology that analyzes CT images to identify hidden features of cardiovascular risk and guide personalized treatment of coronary artery disease.

AI & Machine LearningHealthtechMedical Devices

Co-investorsAngel Physicians FundAphelion CapitalIAG Capital Partners

Gtmedtechgtmedtech.comin𝕏

GT Medical Technologies develops GammaTile, an implantable radiation therapy device for treating operable brain tumors.

BiotechHealthtechMedical Devices

Co-investorsAccelmed PartnersEvidity Health CapitalFemHealth Ventures

NTx Biontxbio.comin

NTx Bio develops proprietary cell-free synthetic biology platforms for on-demand, decentralized biomanufacturing of mRNA and proteins.

BiotechDeep TechHardwareHealthtech

Co-investorsAnzu Partners

Paradigmdxparadigmdx.comin𝕏

Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions.

BiotechDigital HealthHealthtech

Co-investorsNew Science Ventures

Preludedxpreludedx.comin𝕏

PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes.

AI & Machine LearningBiotechHealthtechMedical DevicesNashville, US

Troy Bremer(Co-founder & Chief Scientific Officer)Daniel Forche(President & CEO)

Co-investorsFjord VenturesEvidity Health Capital

Pyx Healthpyxhealth.comin

Pyx Health provides a member engagement and activation solution for health plans, combining in-home fresh food delivery, human care teams, and a digital app to address non-medical drivers of health such as loneliness and food needs.

Digital HealthHealthtechWellness & FitnessTucson, US

Cynthia Jordan(Executive Officer, Director)

Co-investorsArizona Founders FundS2G InvestmentsFounders Fund

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

Elucid BioimagingGT Medical TechnologiesNature's Toolbox

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.